As the global medtech regulatory landscape becomes more complex, having access to comprehensive and up-to-date regulatory intelligence data is critical for successful market placement. Yet, traditional, manual approaches to regulatory intelligence data collection and management can lead to inaccuracies and ultimately costly compliance risks.  

While advancements in digital technologies and AI can help regulatory teams track and manage intelligence data more effectively, they must be used thoughtfully in order to leverage their full benefits, strengthen compliance, and innovate faster.  

Join Rimsys and Intellias for an interactive virtual event on Thursday, October 3, at 1 PM ET as we explore:

• How regulatory intelligence is being defined and used among medtech teams 
• How AI is impacting the regulatory affairs function, enabling teams to manage and organize vast amounts of regulatory data and streamline compliance processes 
• Common misconceptions about and pitfalls to avoid with AI 
• A look at emerging regulatory intelligence and AI technologies on the market 

We’ll also hold a Q&A session at the end, so bring your questions!